Global Cataract Therapeutics Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: August 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Cataract Therapeutics Market was valued at $9.5 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 6.0% CAGR, to an estimated market size of $12.7 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global cataract therapeutics market encompasses pharmacological interventions, such as anti-inflammatory and antibiotic drugs used for post-operative care, and intraocular lenses (IOLs) implanted to restore vision. The scope excludes diagnostic imaging systems and general surgical hardware like phacoemulsification consoles, focusing instead on the therapeutic agents and implantable devices that directly address lens clouding and surgical recovery.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Cataract Therapeutics Market in the period 2025-30:
- The rapidly aging geriatric population remains the primary market driver as the prevalence of age-related cataracts continues to rise globally.
- There is a significant shift toward premium intraocular lenses (IOLs), such as multifocal and toric designs, which offer superior visual outcomes and reduce spectacle dependence.
- The integration of artificial intelligence (AI) in preoperative planning and diagnostic imaging is improving the accuracy of lens selection and surgical predictability.
- Increased adoption of minimally invasive surgical techniques, including femtosecond laser-assisted cataract surgery (FLACS), is enhancing precision and reducing patient recovery times.
- A growing preference for ambulatory surgical centers (ASCs) over traditional hospitals is driving efficiency and increasing the volume of outpatient procedures.
- The development of innovative drug delivery systems, such as sustained-release implants, is addressing the need for better patient compliance in post-operative care.
- Rising healthcare infrastructure investment in emerging markets, particularly China and India, is significantly expanding access to advanced cataract treatments.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- Pharmacological Treatments
- Intraocular Lenses (IOLs)